Description of Business and Basis of Presentation (Details Narrative) - USD ($)					1 Months Ended		3 Months Ended				6 Months Ended		8 Months Ended
	Jul. 23, 2020	Jun. 30, 2020	Feb. 25, 2020	Apr. 30, 2019	Aug. 31, 2020	Jul. 31, 2020	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Net losses							$ 582,091	$ (4,657,894)	$ (1,189,110)	$ (976,063)	$ (4,075,803)	$ (2,165,173)
Working capital		$ (7,400,000)					(7,400,000)				(7,400,000)
Contingent liability		2,600,000					2,600,000				2,600,000
Service Revenue							1,400,000				1,740,855
Subsequent Event [Member]
Number of shares issued and sold	10
Vuong Trieu, CEO [Member]
Funded amount		70,000					70,000				70,000
JH Darbie & Co., Inc. [Member] | Minimum [Member]
Number of shares issued and sold			40
JH Darbie & Co., Inc. [Member] | Maximum [Member]
Number of shares issued and sold			100
JH Darbie & Co., Inc. [Member] | Subsequent Event [Member]
Proceeds from private placement					$ 2,500,000	$ 2,500,000
Placement agent fees					$ 321,000	$ 321,000
GMP and Autotelic BIO [Member]
Service Revenue											1,700,000
Supplemental Agreement [Member] | Oncotelic, Inc. [Member]
Payment for services		500,000
Supplemental Agreement [Member] | Golden Mountain Partners LLC [Member]
Payment for services				$ 1,200,000
Supplemental Agreement [Member] | Golden Mountain Partners LLC [Member] | Vuong Trieu [Member]
Debt financing		$ 2,000,000					$ 2,000,000				$ 2,000,000
Debt term		1 year
Interest rate		2.00%					2.00%				2.00%
Since Inception Date [Member]
Net losses											$ 16,200,000
Assumed working capital		$ (1,300,000)					$ (1,300,000)				$ (1,300,000)
Securities Purchase Agreement [Member] | Two Notes Payable [Member]
Proceeds from notes payable													$ 2,000,000